SAT0096 Serum hepcidin level is a surrogate marker of disease activity but does not independently pr...
SAT0096 Serum hepcidin level is a surrogate marker of disease activity but does not independently predict radiographic progression in early rheumatoid arthritis: Results from the ESPOIR cohort
About this item
Full title
Author / Creator
Sellam, J. , Kotti, S. , Fellahi, S. , Bastard, J.-P. , Meyer, M. , Lioté, F. , Meyer, O. , Simon, T. , Capeau, J. and Berenbaum, F.
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
More information
Scope and Contents
Contents
Background Hepcidin is an interleukin 6-induced peptide hormone produced by the liver and involved in iron homeostasis and inflammation. Previous published studies have suggested that hepcidin could be a key biomarker of severity in rheumatoid arthritis (RA). Objectives We investigated whether serum hepcidin level may represent a novel surrogate bi...
Alternative Titles
Full title
SAT0096 Serum hepcidin level is a surrogate marker of disease activity but does not independently predict radiographic progression in early rheumatoid arthritis: Results from the ESPOIR cohort
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1777973556
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777973556
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2012-eular.3043
